Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Becton Dickinson Tackles Its ESG Strategy

Keypoints: Sarah Hill guides BD’s ESG initiatives and strategy. In her role, she meets with stakeholders and focuses on sustainability disclosures and reporting. Hill identifies essential environmental and social governance issues at the company. Commentary: On this episode of The Energy Exchange, Host David Hidinger talked with Sarah Hill, Director of Sustainability at Becton…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Keypoints:

  • Sarah Hill guides BD’s ESG initiatives and strategy.
  • In her role, she meets with stakeholders and focuses on sustainability disclosures and reporting.
  • Hill identifies essential environmental and social governance issues at the company.

Commentary:

On this episode of The Energy Exchange, Host David Hidinger talked with Sarah Hill, Director of Sustainability at Becton Dickinson (BD), one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. They talked about BD, the importance of ESG, and Hill’s career.

Before landing at BD, Hill worked for one of BD’s competitors as a Product Stewardship Manager and Sustainability manager, where she wore many hats and took on many roles. Her duties focused on product compliance, environmental legislation compliance for medical devices, and a small amount of sustainability strategy work. An opportunity opened up at BD, so she made the move.

“My role is Director of Sustainability, but I still wear a couple of different hats,” Hill said. “I haven’t moved completely away from the product stewardship work, so I still partner with colleagues on my time and the rest of the business on various stewardship issues.”

But, primarily, she focuses on sustainability disclosures, such as sustainability reporting, “an alphabet soup of frameworks we have to follow.” She also engages with stakeholders, such as investors, customers, suppliers, and associates. She is also in charge of setting up their sustainability strategy.

“Working with partners around the business to identify what are important environmental and social governance issues, figure out where we need to go in the next ten years, what’s important for our stakeholders, and get a strategy together,” Hill said.

Are Oil and Gas Companies Leveraging ESG Strategies Enough?

Fossil Fuel 2030 Reduction Goal Not Expected to Be Met

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512